Determinant factors of sarcopenia in individuals with Parkinson’s disease
Objective Evaluate the occurrence of sarcopenia and determinant factors in individuals with Parkinson’s disease (PD) in a city in northeastern Brazil. Methods Case series with 77 men and women (adults and older adults) with PD. The risk of sarcopenia was determined using the SARC-F and SARC-CalF scr...
Gespeichert in:
Veröffentlicht in: | Neurological sciences 2021-03, Vol.42 (3), p.979-985 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 985 |
---|---|
container_issue | 3 |
container_start_page | 979 |
container_title | Neurological sciences |
container_volume | 42 |
creator | da Luz, Marcella Campos Lima Bezerra, Gleyce Kelly Araújo Asano, Amdore Guescel C. Chaves de Lemos, Maria da Conceição Cabral, Poliana Coelho |
description | Objective
Evaluate the occurrence of sarcopenia and determinant factors in individuals with Parkinson’s disease (PD) in a city in northeastern Brazil.
Methods
Case series with 77 men and women (adults and older adults) with PD. The risk of sarcopenia was determined using the SARC-F and SARC-CalF screening tools. The diagnosis of sarcopenia was based on the new consensus published by the European Working Group on Sarcopenia in Older People (EWGSOP2). Sarcopenic obesity was diagnosed based on the criteria proposed by Stenholm. Disease stage and severity were determined using the Hoehn and Yahr scale and the Unified Parkinson Disease Rating Scale, respectively.
Results
The prevalence of sarcopenia was 19.5% and was associated with age, poor performance on activities of daily living and poor nutritional status. No significant association was found between the SARC-F score and the diagnosis of sarcopenia. The main factors that determined the variation in the parameters for the diagnosis of sarcopenia in the present sample were age, disease severity, body weight, and SARCF score.
Conclusion
Despite the low prevalence in the present study, sarcopenia progresses with the worsening of the nutritional status and functional capacity of individuals with PD. Further studies are needed on the factors involved in the genesis of sarcopenia. The SARC-F questionnaire is related to parameters for the diagnosis and severity of sarcopenia as well as the severity of PD. |
doi_str_mv | 10.1007/s10072-020-04601-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2425593649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487162724</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c3124548dcb72e5f8b8bc45150867a2ab8c55233f69245b85fd9fbd204106553</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotlZfwIUMuHEzmusks5R6xYIuug-ZTKKpbaYmM4o7X8PX80lMnargQggngfOdP4cPgH0EjxGE_CSuKs4hhjmkBUQ53QBDxEqYE8rF5vqNBKcDsBPjDEKIKCLbYEBwIQgrxBDcnJnWhIXzyreZVbptQswam0UVdLM03qnM-XRq9-zqTs1j9uLah-xOhUfnY-M_3t5jVrtoVDS7YMsmwuyt7xGYXpxPx1f55Pbyenw6yTXhrE0VYcqoqHXFsWFWVKLSlCEGRcEVVpXQjGFCbFEmrhLM1qWtagwpggVjZASO-thlaJ46E1u5cFGb-Vx503RRYooZK0lBy4Qe_kFnTRd8Wi5RgqMCc0wThXtKhybGYKxcBrdQ4VUiKFeOZW9aJtPyy7RcDR2so7tqYeqfkW-1CSA9EFPL35vw-_c_sZ-HKIiw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487162724</pqid></control><display><type>article</type><title>Determinant factors of sarcopenia in individuals with Parkinson’s disease</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>da Luz, Marcella Campos Lima ; Bezerra, Gleyce Kelly Araújo ; Asano, Amdore Guescel C. ; Chaves de Lemos, Maria da Conceição ; Cabral, Poliana Coelho</creator><creatorcontrib>da Luz, Marcella Campos Lima ; Bezerra, Gleyce Kelly Araújo ; Asano, Amdore Guescel C. ; Chaves de Lemos, Maria da Conceição ; Cabral, Poliana Coelho</creatorcontrib><description>Objective
Evaluate the occurrence of sarcopenia and determinant factors in individuals with Parkinson’s disease (PD) in a city in northeastern Brazil.
Methods
Case series with 77 men and women (adults and older adults) with PD. The risk of sarcopenia was determined using the SARC-F and SARC-CalF screening tools. The diagnosis of sarcopenia was based on the new consensus published by the European Working Group on Sarcopenia in Older People (EWGSOP2). Sarcopenic obesity was diagnosed based on the criteria proposed by Stenholm. Disease stage and severity were determined using the Hoehn and Yahr scale and the Unified Parkinson Disease Rating Scale, respectively.
Results
The prevalence of sarcopenia was 19.5% and was associated with age, poor performance on activities of daily living and poor nutritional status. No significant association was found between the SARC-F score and the diagnosis of sarcopenia. The main factors that determined the variation in the parameters for the diagnosis of sarcopenia in the present sample were age, disease severity, body weight, and SARCF score.
Conclusion
Despite the low prevalence in the present study, sarcopenia progresses with the worsening of the nutritional status and functional capacity of individuals with PD. Further studies are needed on the factors involved in the genesis of sarcopenia. The SARC-F questionnaire is related to parameters for the diagnosis and severity of sarcopenia as well as the severity of PD.</description><identifier>ISSN: 1590-1874</identifier><identifier>EISSN: 1590-3478</identifier><identifier>DOI: 10.1007/s10072-020-04601-4</identifier><identifier>PMID: 32683568</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Activities of Daily Living ; Aged ; Aged, 80 and over ; Body weight ; Brazil - epidemiology ; Cross-Sectional Studies ; Diagnosis ; Female ; Geriatric Assessment ; Humans ; Male ; Medicine ; Medicine & Public Health ; Movement disorders ; Neurodegenerative diseases ; Neurology ; Neuroradiology ; Neurosciences ; Neurosurgery ; Nutritional status ; Older people ; Original Article ; Parkinson Disease - complications ; Parkinson Disease - diagnosis ; Parkinson Disease - epidemiology ; Parkinson's disease ; Psychiatry ; Sarcopenia ; Sarcopenia - diagnosis ; Sarcopenia - epidemiology ; Surveys and Questionnaires</subject><ispartof>Neurological sciences, 2021-03, Vol.42 (3), p.979-985</ispartof><rights>Fondazione Società Italiana di Neurologia 2020</rights><rights>Fondazione Società Italiana di Neurologia 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c3124548dcb72e5f8b8bc45150867a2ab8c55233f69245b85fd9fbd204106553</citedby><cites>FETCH-LOGICAL-c375t-c3124548dcb72e5f8b8bc45150867a2ab8c55233f69245b85fd9fbd204106553</cites><orcidid>0000-0002-9388-7389 ; 0000-0001-9226-1387 ; 0000-0002-2709-4823 ; 0000-0003-3292-7209</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10072-020-04601-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10072-020-04601-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32683568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Luz, Marcella Campos Lima</creatorcontrib><creatorcontrib>Bezerra, Gleyce Kelly Araújo</creatorcontrib><creatorcontrib>Asano, Amdore Guescel C.</creatorcontrib><creatorcontrib>Chaves de Lemos, Maria da Conceição</creatorcontrib><creatorcontrib>Cabral, Poliana Coelho</creatorcontrib><title>Determinant factors of sarcopenia in individuals with Parkinson’s disease</title><title>Neurological sciences</title><addtitle>Neurol Sci</addtitle><addtitle>Neurol Sci</addtitle><description>Objective
Evaluate the occurrence of sarcopenia and determinant factors in individuals with Parkinson’s disease (PD) in a city in northeastern Brazil.
Methods
Case series with 77 men and women (adults and older adults) with PD. The risk of sarcopenia was determined using the SARC-F and SARC-CalF screening tools. The diagnosis of sarcopenia was based on the new consensus published by the European Working Group on Sarcopenia in Older People (EWGSOP2). Sarcopenic obesity was diagnosed based on the criteria proposed by Stenholm. Disease stage and severity were determined using the Hoehn and Yahr scale and the Unified Parkinson Disease Rating Scale, respectively.
Results
The prevalence of sarcopenia was 19.5% and was associated with age, poor performance on activities of daily living and poor nutritional status. No significant association was found between the SARC-F score and the diagnosis of sarcopenia. The main factors that determined the variation in the parameters for the diagnosis of sarcopenia in the present sample were age, disease severity, body weight, and SARCF score.
Conclusion
Despite the low prevalence in the present study, sarcopenia progresses with the worsening of the nutritional status and functional capacity of individuals with PD. Further studies are needed on the factors involved in the genesis of sarcopenia. The SARC-F questionnaire is related to parameters for the diagnosis and severity of sarcopenia as well as the severity of PD.</description><subject>Activities of Daily Living</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Body weight</subject><subject>Brazil - epidemiology</subject><subject>Cross-Sectional Studies</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Geriatric Assessment</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Nutritional status</subject><subject>Older people</subject><subject>Original Article</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - epidemiology</subject><subject>Parkinson's disease</subject><subject>Psychiatry</subject><subject>Sarcopenia</subject><subject>Sarcopenia - diagnosis</subject><subject>Sarcopenia - epidemiology</subject><subject>Surveys and Questionnaires</subject><issn>1590-1874</issn><issn>1590-3478</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kMtKAzEUhoMotlZfwIUMuHEzmusks5R6xYIuug-ZTKKpbaYmM4o7X8PX80lMnargQggngfOdP4cPgH0EjxGE_CSuKs4hhjmkBUQ53QBDxEqYE8rF5vqNBKcDsBPjDEKIKCLbYEBwIQgrxBDcnJnWhIXzyreZVbptQswam0UVdLM03qnM-XRq9-zqTs1j9uLah-xOhUfnY-M_3t5jVrtoVDS7YMsmwuyt7xGYXpxPx1f55Pbyenw6yTXhrE0VYcqoqHXFsWFWVKLSlCEGRcEVVpXQjGFCbFEmrhLM1qWtagwpggVjZASO-thlaJ46E1u5cFGb-Vx503RRYooZK0lBy4Qe_kFnTRd8Wi5RgqMCc0wThXtKhybGYKxcBrdQ4VUiKFeOZW9aJtPyy7RcDR2so7tqYeqfkW-1CSA9EFPL35vw-_c_sZ-HKIiw</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>da Luz, Marcella Campos Lima</creator><creator>Bezerra, Gleyce Kelly Araújo</creator><creator>Asano, Amdore Guescel C.</creator><creator>Chaves de Lemos, Maria da Conceição</creator><creator>Cabral, Poliana Coelho</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9388-7389</orcidid><orcidid>https://orcid.org/0000-0001-9226-1387</orcidid><orcidid>https://orcid.org/0000-0002-2709-4823</orcidid><orcidid>https://orcid.org/0000-0003-3292-7209</orcidid></search><sort><creationdate>20210301</creationdate><title>Determinant factors of sarcopenia in individuals with Parkinson’s disease</title><author>da Luz, Marcella Campos Lima ; Bezerra, Gleyce Kelly Araújo ; Asano, Amdore Guescel C. ; Chaves de Lemos, Maria da Conceição ; Cabral, Poliana Coelho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c3124548dcb72e5f8b8bc45150867a2ab8c55233f69245b85fd9fbd204106553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Activities of Daily Living</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Body weight</topic><topic>Brazil - epidemiology</topic><topic>Cross-Sectional Studies</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Geriatric Assessment</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Nutritional status</topic><topic>Older people</topic><topic>Original Article</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - epidemiology</topic><topic>Parkinson's disease</topic><topic>Psychiatry</topic><topic>Sarcopenia</topic><topic>Sarcopenia - diagnosis</topic><topic>Sarcopenia - epidemiology</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Luz, Marcella Campos Lima</creatorcontrib><creatorcontrib>Bezerra, Gleyce Kelly Araújo</creatorcontrib><creatorcontrib>Asano, Amdore Guescel C.</creatorcontrib><creatorcontrib>Chaves de Lemos, Maria da Conceição</creatorcontrib><creatorcontrib>Cabral, Poliana Coelho</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Luz, Marcella Campos Lima</au><au>Bezerra, Gleyce Kelly Araújo</au><au>Asano, Amdore Guescel C.</au><au>Chaves de Lemos, Maria da Conceição</au><au>Cabral, Poliana Coelho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determinant factors of sarcopenia in individuals with Parkinson’s disease</atitle><jtitle>Neurological sciences</jtitle><stitle>Neurol Sci</stitle><addtitle>Neurol Sci</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>42</volume><issue>3</issue><spage>979</spage><epage>985</epage><pages>979-985</pages><issn>1590-1874</issn><eissn>1590-3478</eissn><abstract>Objective
Evaluate the occurrence of sarcopenia and determinant factors in individuals with Parkinson’s disease (PD) in a city in northeastern Brazil.
Methods
Case series with 77 men and women (adults and older adults) with PD. The risk of sarcopenia was determined using the SARC-F and SARC-CalF screening tools. The diagnosis of sarcopenia was based on the new consensus published by the European Working Group on Sarcopenia in Older People (EWGSOP2). Sarcopenic obesity was diagnosed based on the criteria proposed by Stenholm. Disease stage and severity were determined using the Hoehn and Yahr scale and the Unified Parkinson Disease Rating Scale, respectively.
Results
The prevalence of sarcopenia was 19.5% and was associated with age, poor performance on activities of daily living and poor nutritional status. No significant association was found between the SARC-F score and the diagnosis of sarcopenia. The main factors that determined the variation in the parameters for the diagnosis of sarcopenia in the present sample were age, disease severity, body weight, and SARCF score.
Conclusion
Despite the low prevalence in the present study, sarcopenia progresses with the worsening of the nutritional status and functional capacity of individuals with PD. Further studies are needed on the factors involved in the genesis of sarcopenia. The SARC-F questionnaire is related to parameters for the diagnosis and severity of sarcopenia as well as the severity of PD.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32683568</pmid><doi>10.1007/s10072-020-04601-4</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-9388-7389</orcidid><orcidid>https://orcid.org/0000-0001-9226-1387</orcidid><orcidid>https://orcid.org/0000-0002-2709-4823</orcidid><orcidid>https://orcid.org/0000-0003-3292-7209</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1590-1874 |
ispartof | Neurological sciences, 2021-03, Vol.42 (3), p.979-985 |
issn | 1590-1874 1590-3478 |
language | eng |
recordid | cdi_proquest_miscellaneous_2425593649 |
source | MEDLINE; SpringerNature Journals |
subjects | Activities of Daily Living Aged Aged, 80 and over Body weight Brazil - epidemiology Cross-Sectional Studies Diagnosis Female Geriatric Assessment Humans Male Medicine Medicine & Public Health Movement disorders Neurodegenerative diseases Neurology Neuroradiology Neurosciences Neurosurgery Nutritional status Older people Original Article Parkinson Disease - complications Parkinson Disease - diagnosis Parkinson Disease - epidemiology Parkinson's disease Psychiatry Sarcopenia Sarcopenia - diagnosis Sarcopenia - epidemiology Surveys and Questionnaires |
title | Determinant factors of sarcopenia in individuals with Parkinson’s disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A21%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determinant%20factors%20of%20sarcopenia%20in%20individuals%20with%20Parkinson%E2%80%99s%20disease&rft.jtitle=Neurological%20sciences&rft.au=da%20Luz,%20Marcella%20Campos%20Lima&rft.date=2021-03-01&rft.volume=42&rft.issue=3&rft.spage=979&rft.epage=985&rft.pages=979-985&rft.issn=1590-1874&rft.eissn=1590-3478&rft_id=info:doi/10.1007/s10072-020-04601-4&rft_dat=%3Cproquest_cross%3E2487162724%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487162724&rft_id=info:pmid/32683568&rfr_iscdi=true |